{
  "efficacy_measures": {
    "complete_response": [
      {
        "value": 18.4,
        "pmid": "36455187",
        "source": "EMSCO Network Trial",
        "year": 2023
      }
    ],
    "partial_response": [
      {
        "value": 28.7,
        "pmid": "36455187",
        "source": "EMSCO Network Trial",
        "year": 2023
      }
    ],
    "marrow_cr": [
      {
        "value": 25.2,
        "pmid": "36455187",
        "source": "EMSCO Network Trial",
        "year": 2023
      }
    ],
    "progression_free_survival": [
      {
        "value": 10.2,
        "pmid": "36455187",
        "source": "EMSCO Network Trial",
        "year": 2023
      }
    ],
    "overall_survival": [
      {
        "value": 18.9,
        "pmid": "36455187",
        "source": "EMSCO Network Trial",
        "year": 2023
      }
    ],
    "event_free_survival": [
      {
        "value": 12.1,
        "pmid": "36455187",
        "source": "EMSCO Network Trial",
        "year": 2023
      }
    ]
  },
  "adverse_events": [
    {
      "type": "Grade 3-4 Neutropenia",
      "value": 22.1,
      "pmid": "36455187",
      "source": "EMSCO Network Trial",
      "year": 2023
    },
    {
      "type": "Grade 3-4 Thrombocytopenia",
      "value": 15.3,
      "pmid": "36455187",
      "source": "EMSCO Network Trial",
      "year": 2023
    },
    {
      "type": "Febrile Neutropenia",
      "value": 9.8,
      "pmid": "36455187",
      "source": "EMSCO Network Trial",
      "year": 2023
    }
  ],
  "ras_mutated": [],
  "non_ras_mutated": [],
  "studies": [
    {
      "pmid": "36455187",
      "title": "Decitabine Versus Hydroxyurea for Advanced Proliferative Chronic Myelomonocytic Leukemia",
      "doi": "10.1200/JCO.22.00437",
      "year": 2023
    }
  ]
}